- 10 state behavioral health policy updates
- Mood disorders during menopause: A call to recognize and respond
- Iowa governor signs law to reform prior authorization, out-of-network penalties
- Why rural is the perfect setting for innovation: Mayo Clinic Health System CEO
- Tens of thousands of U of California healthcare, service workers to strike
- 3,000 Endeavor nurses seek unionization
- CoxHealth changes service lines, leadership structure
- Healthcare’s trillion-dollar private equity conundrum
- CMS taps 30 healthcare organizations for prior authorization initiative
- Hantavirus response spans 2 US biocontainment facilities: 6 updates
- Former Phoenix Children’s CEO publishes leadership book
- Dentistry’s biggest players
- Nurses feel left out of AI adoption: Survey
- White House freezes $1.3B in Medicaid payments to California
- Nebraska dentist to retire after 33 years of service
- 23 behavioral health executive moves to know
- Turnover runs high at 22% for early-career nurses: Press Ganey
- The key to dental practices operating like a 5-star hotel
- 5 CMS updates shaping outpatient care in 2026
- 5 major GI groups to know
- MB2 Dental adds 5 new partners in 2 months
- Arizona spine practice opens ASC
- Oklahoma CRNA charged with misconduct
- Kaiser Permanente plans 11K-square-foot MOB in Nevada
- Dentistry’s AI gold rush
- Only 1 in 5 physicians is independent: 10 new numbers behind the collapse
- California physician group acquired by PRISM
- Utah physician, 2 nurses charged in $29M fraud scheme
- CMS to withhold $1.3B in Medicaid funds from California, puts state officials on notice about fraud
- 1 behavioral health leader’s playbook for staff retention and safety
- Behavioral health ED visits projected to rise by 1 million
- 5 dental AI updates in 1 month
- 3 lawsuit settlements in dentistry
- BeOne's Venclexta challenger Beqalzi nets FDA approval as first BCL-2 for mantle cell lymphoma
- Financial pressures shutter Iowa dental clinics: 4 notes
- Independent autism research committee adds 7 members
- FDA Commissioner Marty Makary Resigns After Trump Pressure
- 10 notes on the widening DSO performance gap
- New payer-backed ad campaign pushes for No Surprises Act IDR reform
- CDC-linked autism researcher arraigned on fraud charges
- Nearly 1 in 3 boys under 14 discussed suicide in crisis conversations: Report
- Docs more burnt out, skeptical of AI than nurses, survey report finds
- As Trump arrives in China, Big Pharma CEOs are notably absent
- Remarks at the MFA Legal & Compliance 2026 Conference
- CMS pauses hospice, home health Medicare enrollments in fraud crackdown
- GLP-1 Drugs May Improve Breast Cancer Outcomes
- NYU Langone Health says it received grand jury subpoena over gender-affirming care
- Merck KGaA looks to M&A to bolster its 'rather slim' pipeline
- Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
- BeOne Medicines’ Brukinsa TV ad 'Clarity' hit by FDA over 'misleading suggestions'
- Health systems are exploring AI-powered cardiac risk screening. New CMS reimbursement could unlock a business case for it
- Ted Turner's Brain Disease More Common Than Previously Thought, Review Finds
- Most mental health practitioners satisfied with work, financially stable, SimplePractice finds
- Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies
- Haleon tackles sports injuries with latest soccer play
- Perimenopausal Women Face Greater Heart Risk, Study Finds
- Ivermectin Prescriptions Doubled After Mel Gibson Cancer Cure Claim
- Eating Out Linked To Obesity Risk Worldwide
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- Trump and Kennedy Seek To Relax Safeguards for AI Healthcare Tools
- RFK Jr. Swaps Vaccine Talk for Healthy Foods and Reading to Tots in Push To Woo Voters
- Valneva to lay off up to 15% of workforce in face of ‘adverse trend’ in travel vaccines
- California to award $111M for behavioral health supportive housing
- 6 new psychiatric residency programs to know
- USOSM adds New York practice
- Mayo Clinic CEO Gianrico Farrugia stepping down at year's end
- BioMarin consolidates staff at Amicus HQ after closing $4.8B deal for rare disease peer
- US Monitors For Hantavirus As WHO Expects More Cases But 'Not Another COVID'
- University of California, union near May 14 strike deadline with no deal in hand
- 1 in 5 marketplace enrollees dropped their coverage in 2026: media report
- Hims & Hers posts $92M loss in Q1 as it shifts to branded GLP-1 medications
- Listen to the Latest ‘KFF Health News Minute’
- FDA Commissioner Marty Makary to resign, capping turbulent tenure
- FDA Commissioner Marty Makary to resign, capping turbulent tenure
- Providence puts years of losses in rearview with its third consecutive quarter of operating gains
- Millions of Women Suffer in Silence From Treatable Pelvic Organ Prolapse
- Eli Lilly pauses Indian obesity awareness campaign after regulatory notices: report
- Optum Rx unveils new transparent PBM model
- Fitness wearable Whoop adds on-demand clinician access, EHR syncing
- Alkermes’ Lumryz hits phase 3 mark in another sleep disorder, fueling momentum from $2.4B Avadel acquisition
- ACA exchanges take spotlight in Q1
- Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu
- Bayer's Eylea declines by 24%, bearing the brunt of biosmilar competition
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- What's Fueling The High U.S. Death Rate? It Might Not Be What You Think
- Telemedicine Not Breaking The Bank, Also Not Expanding Patient Access
- After-School Sports An Overall Boon To Children And Teens, Study Shows
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up
- Why Are Older Adults Taking Edibles? Survey Reveals Some Surprises
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- EU advances scheme to bolster manufacturing autonomy, avert drug shortages
- Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer
- The broken pipeline of mental healthcare for LGBTQ teenagers
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- Is your hospital ready for a prolonged IT outage? Joint Commission, AHA's new resiliency program will let you know
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- Roche acquires PathAI to transform AI-driven diagnostics
- Roche acquires PathAI to transform AI-driven diagnostics
- Trump Planning to Fire FDA Commissioner Marty Makary
- Trump Planning to Fire FDA Commissioner Marty Makary
- Included Health launches AI-powered solution to connect members to providers
- FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer
- The Hidden Design Flaw in Medical Device Service Technology
- The Hidden Design Flaw in Medical Device Service Technology
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- 8,500 Steps A Day Could Be Sweet Spot For Preventing Weight Regain
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Survey: Employers seeking greater transparency from pharmacy benefits
- Kaiser Permanente's investments pick up the slack as Q1 operating margin slims to 2.1%
- AMA unveils policy framework to combat AI deepfake physician impersonation
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- CSL slashes revenue projection and takes $5B impairment as interim CEO flags R&D misses, market erosion
- Healthcare bankruptcies up 33% in Q1 2026: report
- Why Doctors Are Quitting At An Earlier Age
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Older Adults Have Fewer Regrets, Study Says
- Partner's bispecific Bizengri nabs FDA national priority nod in rare bile duct cancer
- Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan
- That Discount At The Pharmacy Counter May Pack Hidden Costs
- Nighttime Heat Waves Increase Asthma Risk
- As Ranks of Uninsured Grow, Minnesota’s Hospitals Are Among Least Charitable in Nation
- Watch: 8 Health Insurance Terms You Should Know
- OVID Health hires Edelman alum Davide Scalenghe to boost its international footprint
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Eli Lilly shoots for health in new Caitlin Clark ad campaign
- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- The Make America Healthy Again Movement Comes for Hospital Food
- Remarks at the Conference on Financial Market Regulation
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Skil-Care launches specialized healthcare product innovation program
- Remarks at the Special Competitive Studies Project AI+ Expo
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- Remarks at the 13th Annual Conference on Financial Market Regulation
Vice President JD Vance's anti-fraud task force has blocked new hospice and home healthcare and hospice providers from enrolling in Medicare for at least six months. This echoes the February pause in Medicare enrollments of durable medical equipment suppliers due to widespread fraud:
Exclusive: US freezes Medicare enrollments for new home healthcare and hospice providers
By Jody Godoy and Courtney Rozen - May 13, 2026Summary
- Move is part of Vance task force on healthcare scams
- Pause will give government time to scrutinize accounts
- Fraud crackdown began in Minnesota
May 13 (Reuters) - The Trump administration will block new home healthcare and hospice providers from enrolling in Medicare for at least the next six months, according to a government statement posted on Wednesday, citing concerns about widespread fraud.
The moratorium will temporarily bar new providers in those categories from signing up for reimbursement from Medicare, a U.S. government health insurance program for Americans aged 65 and older and those with disabilities. It will not impact providers already registered with Medicare, according to the Centers for Medicare & Medicaid Services, which oversees the program.
It is the latest move by Vice President JD Vance's anti-fraud task force that aims to crack down on healthcare scams.
The U.S. government has for years tried to tackle fraudulent payments from Medicare to hospice and home healthcare providers.
Scammers can bill Medicare for hospice or home healthcare services that the patient doesn't need or want, allowing them to rake in millions of dollars from the U.S. government. The national fraud prevention group Senior Medicare Patrol has repeatedly issued alerts on the issue.
CMS has paused enrollments in the past in specific counties when staff suspected fraud, including in 2013, when it barred new providers based in Florida's Miami-Dade County.
"This is about protecting patients, restoring integrity and safeguarding taxpayer dollars," said CMS Administrator Mehmet Oz in a statement.
Reuters was first to report on the pause. The moratorium will give CMS time to account for hospice and home health expenditures under the Medicare program and create additional guidance, an administration official said.
The Trump administration has been criticized for mixing the president's political preferences with agency efforts to eliminate fraud in government payments. The administration singled out some Democratic-led states, including California and Minnesota, as not doing enough to combat fraud. But it also ramped up oversight of hospices in Georgia and Ohio last year, both led by Republicans.
DIFFERENT APPROACHES FROM INDUSTRY
In 2024, 1.8 million Medicare beneficiaries received hospice care at a cost of $28.3 billion, according to the Medicare Payment Advisory Commission. The same year, 2.7 million patients on Medicare received home healthcare at a cost of $16 billion, according to the agency which advises Congress on healthcare spending.
Vance's task force has recently taken action against hospice services, particularly in California, where the state auditor said in 2022 that lax oversight had enabled large-scale fraud.
Industry groups had urged different approaches as the Trump administration weighed potential action.
The National Partnership for Healthcare and Hospice Innovation said in March it supported temporarily pausing hospice provider enrollments. The National Alliance for Care at Home warned against overly broad action that could deter doctors and patients from recommending or seeking care.
Major home health operators in the U.S. include BrightSpring Health Services (BTSG.O), opens new tab, private equity-backed Matrix Medical Network, and UnitedHealth Group (UNH.N), opens new tab. Chemed Corporation (CHE.N), opens new tab subsidiary VITAS Healthcare is among the top hospice care providers.
BROADER CRACKDOWN
Tens of billions of dollars are estimated to be lost in the United States through healthcare fraud each year, translating into higher costs for patients and employers, according to the National Health Care Anti-Fraud Association.
The administration of U.S. President Donald Trump has also sought to tackle other healthcare sectors it has deemed a fraud risk. The administration in February paused Medicare enrollments by suppliers of durable medical equipment, such as prostheses.
The fraud crackdown started in Minnesota, where the Trump administration said in February it would withhold $259 million in funds for Medicaid, the federal- and state-run program for lower-income Americans.
Trump has repeatedly invoked a scandal in Minnesota that dates back to 2020, in which 47 people were accused of defrauding $250 million from a state-run, federally funded child nutrition program. Many of the defendants in that case were Somali Americans, according to local news reports.
The controversy prompted Trump earlier this year to send in thousands of federal immigration officers as part of a migrant crackdown. He shifted tactics to a less aggressive approach after federal officers shot dead two people protesting his policies.
In announcing the fraud task force in March, Trump, without providing evidence, said fraud allegations were higher in Democratic-led states than in Republican-led states.
The CMS press release:
CMS Announces Aggressive Nationwide Crackdown on Fraud with Six-Month Hospice and Home Health Agency Enrollment Moratoria
Press Releases - May 13, 2026Action Builds on Administration’s Whole-of-Government Effort to Crush Fraud and Protect Medicare
In coordination with Vice President JD Vance’s Anti-Fraud Task Force, the Centers for Medicare & Medicaid Services (CMS) is taking decisive action to protect Medicare beneficiaries and taxpayer dollars through implementation of a six-month, nationwide data-driven moratoria on new Medicare enrollment for hospices and home health agencies (HHAs). The moratoria will allow CMS to temporarily halt the influx of new providers into these high-risk categories—a key source of fraudulent activity. Today’s move continues the Trump Administration’s crackdown on fraud, waste, and abuse in the Medicare program by stopping improper billing and preventing bad actors from entering the system.
“We’ve seen systemic and deeply troubling fraud in the hospice and home health space, with bad actors exploiting some of our most vulnerable Medicare patients and stealing money from the American taxpayer,” said CMS Administrator Dr. Mehmet Oz. “Today we’re shutting the door on fraud—preventing new bad actors from entering Medicare while we aggressively identify, investigate, and remove those already exploiting them. This is about protecting patients, restoring integrity, and safeguarding taxpayer dollars.”
During the six-month moratoria, CMS will intensify targeted investigations, deploy advanced data analytics, and accelerate the removal of hospice and HHA providers from the Medicare program that are suspected of committing fraud. This nationwide approach will also eliminate the ability of bad actor operators to evade detection by simply shifting across state lines. In addition, the moratoria will apply to all applications for initial Medicare enrollment and certain changes in majority ownership, which are frequently used to obscure control by bad actors. The moratoria will not impact current enrollments, and existing providers can continue to deliver services to Medicare beneficiaries.
CMS’ announcement today follows our declaration earlier this year of a similar moratorium to prevent fraudulent Medicare billing by certain durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) companies. With three separate moratoria now in place, CMS has taken some of the most significant fraud prevention actions in the agency’s history.
The moratoria are part of CMS’ ongoing efforts to stop fraud before it starts, using data-driven prevention and real-time enforcement as part of a coordinated federal approach. Recent CMS action, undertaken in coordination with Vice President JD Vance’s Anti-Fraud Task Force, has included the suspension of payments to 773 hospices and 23 HHAs suspected of fraud in Los Angeles alone, representing $70 million in suspended funds thus far.
Additional CMS work to crush fraud in the hospice and HHA areas has included:
- Revoking or deactivating hundreds of hospices and HHAs engaged in improper or fraudulent activity;
- Conducting nationwide hospice site visits to verify operations and identify suspicious activity;
- Heightened oversight of newly enrolled Medicare hospice providers in states with elevated fraud risk, including Arizona, California, Georgia, Ohio, Nevada, and Texas;
- Launching a new, publicly available hospice scoring system to increase transparency and identify providers with troubling patterns of utilization, quality, or compliance;
- Implementing enhanced enrollment screening measures for high-risk HHAs, including site verification of reported practice locations and fingerprinting-based background checks; and
- Expanding a demonstration project that allows pre- and post-claim review of HHA claims in Florida, Illinois, Oklahoma, Ohio, North Carolina, and Texas to stop improper payments before they occur.
Additional information on the Hospice and Home Health Agency moratoria can be found via the Federal Register at: https://www.federalregister.gov/d/2026-09717 (Home Health) and https://www.federalregister.gov/d/2026-09718 (Hospice).
Learn more about CMS’ fraud prevention efforts online at https://www.cms.gov/fraud
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















